Evidence map›Paper›PMID 34854280›Full record

ArticleHaematologica2022

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas.

Sophie Candon, Veronique Lemee, Emilie Leveque, Pascaline Etancelin, Cedric Paquin, Marion Carette, Nathalie Contentin, Victor Bobee, Mustafa Alani, Nathalie Cardinael and 16 more

Abstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sophie CandonLaboratory of Immunology and Biotherapies, Rouen University Hospital; INSERM U1234, University of Rouen Normandy, Rouen.
Veronique LemeeNormandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of virology, F-76000 Rouen.
Emilie LevequeUnit of Clinical Research, Centre Henri Becquerel, 76038, Rouen.
Pascaline EtancelinDepartment of Biopathology, Centre Henri Becquerel, 76038, Rouen.
Cedric PaquinDepartment of Biopathology, Centre Henri Becquerel, 76038, Rouen.
Marion CaretteLaboratory of Immunology and Biotherapies, Rouen University Hospital.
Nathalie ContentinDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Victor BobeeLaboratory of Hematology, Rouen University Hospital.
Mustafa AlaniDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Nathalie CardinaelDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Stephane LepretreDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Vincent CamusDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Florian BoucletDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Edwige BouletCliniques universitaires UCL de Mont Godinne, 5530, Namur, Belgique.
Anne-Lise MenardDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Helene LanicDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Aspasia StamatoullasDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen, France; INSERM U1245, University of Rouen Normandy, Rouen.
Emilie LemasleDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Louis-Ferdinand PepinUnit of Clinical Research, Centre Henri Becquerel, 76038, Rouen.
Doriane RichardUnit of Clinical Research, Centre Henri Becquerel, 76038, Rouen.
Sydney DuboisDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
Herve TillyDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen, France; INSERM U1245, University of Rouen Normandy, Rouen.
Alain DalleacDepartment of Biopathology, Centre Henri Becquerel, 76038, Rouen.
Jean-Christophe PlantierNormandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of virology, F-76000 Rouen.
Manuel EtienneNormandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of infectious diseases, F-76000 Rouen.
Fabrice JardinDepartment of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen, France; INSERM U1245, University of Rouen Normandy, Rouen. fabrice.jardin@chb.unicancer.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-CellVaccinesAntibodies, MonoclonalAntibodies, ViralBNT162 VaccineHumansImmunity, CellularAntibodies, MonoclonalAntibodies, ViralBNT162 VaccineVaccines

Identifiers

PMID34854280
PMCPMC8883534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.